Sarah E. Dunsmore

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19”.

Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19

New England Journal of Medicine(2023)10.1056/nejmoa2209421

N/A

0.781DataRank · unranked

26 citations

Christopher J. Lindsell, Thomas G. Stewart, Adrian F. Hernandez, Sean P. Collins, Matthew W. McCarthy +18 more

Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial

medRxiv(2025)10.1101/2025.08.08.25333305

N/A

0.224DataRank · unranked

2 citations

Thomas G. Stewart, David R. Boulware, Matthew W. McCarthy, Yue Gao, Russell L. Rothman +23 more

Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation Network

Journal of Clinical and Translational Science(2023)10.1017/cts.2023.560

N/A

0DataRank · unranked

7 citations

Marisha E. Palm, Eve Marion, Marie Kay, Dixie D. Thompson, Mary Stroud +20 more

The Trial Innovation Network Liaison Team: building a national clinical and translational community of practice

Journal of Clinical and Translational Science(2023)10.1017/cts.2023.675

N/A

0DataRank · unranked

1 citations

Dixie D. Thompson, Terri Edwards, Kitt Swartz, Keith Herzog, Shweta Bansal +15 more

Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.561

N/A

0DataRank · unranked

1 citations

Stacey J. Adam, Kevin W. Gibbs, Ari Moskowitz, Thomas L. Ortel, Upinder Singh +13 more

The future is now: Using the lessons learned from the ACTIV COVID-19 therapeutics trials to create an inclusive and efficient clinical trials enterprise

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.622

N/A

0DataRank · unranked

0 citations

Sarah E. Dunsmore, Lisa H. Merck, Sarah W. Read, Yves Rosenberg, Stacey J. Adam

Participant experiences in a decentralized clinical trial using digital health technologies: The ACTIV-6 study

Journal of Clinical and Translational Science(2025)10.1017/cts.2025.69

N/A

0DataRank · unranked

2 citations

Janelle Faiman, Russ Beebe, Jessica S. Marlin, Sean P. Collins, David R. Boulware +9 more

Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned

Journal of Clinical and Translational Science(2023)10.1017/cts.2023.597

N/A

0DataRank · unranked

56 citations

Gordon R. Bernard, Consuelo H. Wilkins, Harry P. Selker, Jamie P. Dwyer, Jay B. Dean +19 more

Metformin at the time of Covid-19 infection and risk of Long Covid: A Target Trial Emulation Study

(2025)10.22541/au.176418398.81170401/v1

N/A

0DataRank · unranked

1 citations

Til Stürmer‎, Jared D. Huling, Jeba Josilin B, Christopher J. Lindsell, Thomas G. Stewart +10 more

Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical Trials

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.36470

N/A

0DataRank · unranked

17 citations

Sarah E. Dunsmore, Jane C. Atkinson, Daniel K. Benjamin, Gordon R. Bernard, Jay B. Dean +95 more